Back to List View Graph View

Simvastatin

Simvastatin is a lipophilic statin used primarily as a cholesterol-lowering therapy.

Where the papers sit

14 papers from the last 6 months study simvastatin directly · updated from PubMed 3 Nov 2026

Those 14 do not share a common subject.

  • Simvastatin is examined across sleep-deprivation neuroinflammation, hyperlipidemia, cirrhosis, pharmacokinetics, cancer, and bone healing. Other entries address drug combinations, formulations, biomaterials, vaccines, emulsions, and synthetic biology without a shared disease focus. The recurring link is biomedical or pharmaceutical investigation rather than one mechanism or endpoint. No coherent research direction emerges from this mixed set.

    14 papers

NEW DIRECTION

Simvastatin is presented as a biosynthetic product rather than as a therapeutic drug

The Komagataella phaffii–Escherichia coli synthetic consortium used simvastatin as a reporter molecule produced through engineered metabolic pathways, achieving 26.2 mg/L from a simple carbon source and extending the platform to naringenin 42492893Jul. Whereas the other studies treat simvastatin as a drug, delivery payload, or treatment component, this work recasts it as an output of an inducible microbial manufacturing system, opening a production and synthetic-biology role outside those therapeutic categories.

simvastatin chemical structure

Papers

The 14 papers from the last 6 months that study simvastatin directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

No clear themes (14)
  1. Simvastatin Modulates Astrocyte and Microglial Reactivity and Aggressive Behavior After Chronic Sleep Deprivation in Rats. Journal of neuroscience research · 1 Nov 2026 PMID 42967864
  2. Serum Pharmacochemistry and Metabolomics Reveal the Mechanism of Hedan Tablets Combined With Simvastatin in Hyperlipidemia Treatment. Biomedical chromatography : BMC · 13 Oct 2026 PMID 42866964
  3. A Strategic Formulation to Enhance the Safety and Anti-Hyperlipidaemic Activity of Simvastatin: Prototype Development. AAPS PharmSciTech · 28 Sept 2026 PMID 42806178
  4. Verification of a Physiologically-based Pharmacokinetic Model for Predicting CYP3A4-mediated Simvastatin and Simvastatin Acid Drug-drug Interactions. The AAPS journal · 10 Sept 2026 PMID 42717157
  5. LIM and SH3 protein 1 deficiency confers resistance to cytotoxic lymphocyte-mediated lysis and immunotherapy in gastric cancer by disrupting cytoskeleton dynamics. Journal for immunotherapy of cancer · 2 Sept 2026 PMID 42686372
  6. Deciphering the Mechanisms of Statin-Ezetimibe Drug Combinations Using Boolean Logical Modeling and Transcriptomic Data. CPT: pharmacometrics & systems pharmacology · 1 Sept 2026 PMID 42678094
  7. Controlled release of simvastatin using a biodegradable polymer for bone healing application. Journal of materials chemistry. B · 1 Sept 2026 PMID 42677821
  8. Effects of Hedan Tablets Combined With Simvastatin on Hyperlipidemia: Insights From Microbiomics and Metabolomics. Biomedical chromatography : BMC · 28 Jul 2026 PMID 42517864
  9. Synthetic yeast-bacterium consortium enables co-inducible relayed synthesis of chemicals. Metabolic engineering · 23 Jul 2026 PMID 42492893
  10. Rescuing Dendritic Cells from Adjuvant Toxicity: Liposomal Ginsenoside Rh2 as a Dual-Action Strategy for Enhanced Vaccine Potency. Molecular pharmaceutics · 7 Jul 2026 PMID 42411873
  11. Simvastatin Treatment in Patients with Liver Cirrhosis: A Phase II Randomized Placebo-Controlled Trial Shows Reduction in IL6 Levels. Cancer prevention research (Philadelphia, Pa.) · 18 Jun 2026 PMID 42310898
  12. Synergistic stabilization of Pickering emulsions by agar-chitosan composite particles and their potential for improving the bioavailability of lipophilic simvastatin. International journal of biological macromolecules · 12 Jun 2026 PMID 42285454
  13. Standardized workflow enables reproducibility of drug synergism detection: Results from a multi-center in vitro ring test on complex drug combinations in pancreatic cancer models. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 1 Jun 2026 PMID 42224741
  14. Development and Characterization of Collagen Composites With Chemically Functionalized Mesoporous Silica Particles for Bone Tissue Engineering Applications. Journal of biomedical materials research. Part A · 28 May 2026 PMID 42206687

By study type

Clinical trials (1)
  1. Simvastatin Treatment in Patients with Liver Cirrhosis: A Phase II Randomized Placebo-Controlled Trial Shows Reduction in IL6 Levels. Cancer prevention research (Philadelphia, Pa.) · 18 Jun 2026 PMID 42310898
Human data, design not indexed (2)
  1. Verification of a Physiologically-based Pharmacokinetic Model for Predicting CYP3A4-mediated Simvastatin and Simvastatin Acid Drug-drug Interactions. The AAPS journal · 10 Sept 2026 PMID 42717157
  2. Deciphering the Mechanisms of Statin-Ezetimibe Drug Combinations Using Boolean Logical Modeling and Transcriptomic Data. CPT: pharmacometrics & systems pharmacology · 1 Sept 2026 PMID 42678094
Preclinical: animal, cell and lab studies (11)
  1. Simvastatin Modulates Astrocyte and Microglial Reactivity and Aggressive Behavior After Chronic Sleep Deprivation in Rats. Journal of neuroscience research · 1 Nov 2026 PMID 42967864
  2. Serum Pharmacochemistry and Metabolomics Reveal the Mechanism of Hedan Tablets Combined With Simvastatin in Hyperlipidemia Treatment. Biomedical chromatography : BMC · 13 Oct 2026 PMID 42866964
  3. A Strategic Formulation to Enhance the Safety and Anti-Hyperlipidaemic Activity of Simvastatin: Prototype Development. AAPS PharmSciTech · 28 Sept 2026 PMID 42806178
  4. LIM and SH3 protein 1 deficiency confers resistance to cytotoxic lymphocyte-mediated lysis and immunotherapy in gastric cancer by disrupting cytoskeleton dynamics. Journal for immunotherapy of cancer · 2 Sept 2026 PMID 42686372
  5. Controlled release of simvastatin using a biodegradable polymer for bone healing application. Journal of materials chemistry. B · 1 Sept 2026 PMID 42677821
  6. Effects of Hedan Tablets Combined With Simvastatin on Hyperlipidemia: Insights From Microbiomics and Metabolomics. Biomedical chromatography : BMC · 28 Jul 2026 PMID 42517864
  7. Synthetic yeast-bacterium consortium enables co-inducible relayed synthesis of chemicals. Metabolic engineering · 23 Jul 2026 PMID 42492893
  8. Rescuing Dendritic Cells from Adjuvant Toxicity: Liposomal Ginsenoside Rh2 as a Dual-Action Strategy for Enhanced Vaccine Potency. Molecular pharmaceutics · 7 Jul 2026 PMID 42411873
  9. Synergistic stabilization of Pickering emulsions by agar-chitosan composite particles and their potential for improving the bioavailability of lipophilic simvastatin. International journal of biological macromolecules · 12 Jun 2026 PMID 42285454
  10. Standardized workflow enables reproducibility of drug synergism detection: Results from a multi-center in vitro ring test on complex drug combinations in pancreatic cancer models. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 1 Jun 2026 PMID 42224741
  11. Development and Characterization of Collagen Composites With Chemically Functionalized Mesoporous Silica Particles for Bone Tissue Engineering Applications. Journal of biomedical materials research. Part A · 28 May 2026 PMID 42206687